Compositions and Methods for Treating a Disease Mediated By Soluble Oligomeric Amyloid Beta
The present invention relates to methods for restoring fast axonal transport in a cell affected by oligomeric amyloid beta and for treating an oligomeric amyloid beta- mediated disease such as Alzheimer's disease using a Casein Kinase 2 inhibitor and, in some embodiments, a Glycogen Synthase Kinase 3 inhibitor.
Attached files:Patents:WO 2,010,096,751
Inventor(s):
BRADY SCOTT THOMAS [US]; MORFINI GERARDO ANDRES [US]; PIGINO GUSTAVO [US]
Type of Offer:
Licensing
« More Medical Patents